Oral Azacitidine (CC-486) Plus R-CHOP in Patients With High-Risk or Previously Untreated Diffuse Large B-Cell Lymphoma, Grade 3B Follicular Lymphoma, or Transformed Lymphoma (AFT-08)
- Citation:
- Blood vol 132 (Suppl 1) 2964
- Meeting Instance:
- ASH 2018
- Year:
- 2018
- Type:
- Abstract
- Sub type:
- Poster Discussion
- Funding:
- AFT
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- epreprint
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- 3481
- Pharmas:
- Celgene
- Grants:
- Corr. Author:
- Authors:
- Peter Martin Nancy L. Bartlett Julio C. Chavez John L. Reagan Sonali M. Smith Ann LaCasce Maria Revuelta Jeffrey Jones James Drew Chengqing Wu Leandro Cerchietti John P. Leonard
- Networks:
- FL310, LAPS-IL057, LAPS-MA036, LAPS-MN026, LAPS-MO011, NEWMEXICO, NY018, RI005, TX041
- Study
- AFT-08
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords: